No Data
No Data
LifeSci Capital Maintains ALX Oncology(ALXO.US) With Hold Rating
ALX Oncology Holdings: Balancing Growth Potential and Uncertainty With a Hold Rating
Why the Global Cancer Market Could Surpass $900 Billion--And the Stocks Leading the Charge
Stifel Maintains ALX Oncology(ALXO.US) With Hold Rating, Cuts Target Price to $1.5
ALX Oncology Is Maintained at Hold by Stifel
ALX Oncology Holdings Shares Are Trading Lower. The Company Reported Q4 Financial Results.